This is a good result, but Claude is still over-closing the case in the last paragraph.
What Track A legitimately tells us is:
Zana does not show the large CNVs associated with the particular hypertrichosis/gigantism loci we selected.
That is meaningful because those known lesions are large enough that a ~3× genome should reveal them, and the Viking normalization plus Khwit inheritance check makes the negative substantially stronger.
But this sentence goes too far:
“Zana was an ordinary Homo sapiens woman who was mythologised.”
Her ancestry already established that she was Homo sapiens. This screen doesn't establish that her phenotype was ordinary. It excludes several specific mechanisms.
Claude actually admits the reason immediately afterward: at this depth, he hasn't tested point mutations adequately, and these loci do not exhaust the genetics of hypertrichosis, unusual growth, craniofacial morphology, etc. There are multiple genetic forms of hypertrichosis alone, plus regulatory mechanisms we don't understand well enough to screen exhaustively.
I'd record the conclusion more narrowly:
No evidence was found for the major known large-CNV mechanisms tested for generalized hypertrichosis or X-linked gigantism, nor for large CNVs at MSTN or SMAD6. Zana remains genetically consistent with ordinary Homo sapiens ancestry, but the available ~3× genome cannot exclude other genetic causes of unusual phenotype.
That's solid.
The SOX3 false positive investigation is excellent, incidentally. That's exactly the sort of mistake we want the pipeline to catch: one weird control creating an apparent Zana deletion. And it proves those Viking downloads weren't entirely an elaborate Scandinavian punishment. 😄
The inherited chr17 gains are potentially worth noting but not chasing unless they overlap something interesting. Shared Zana/Khwit + wrong direction relative to the known CGHT deletions makes “boring inherited CNV” the sensible working interpretation.
And yes, I'd move to Track B now. In fact, Track B is probably more relevant to H4 than Track A ever was. We shouldn't be asking whether a hypothetical population all had diseases. We want to know how far normal viable human variation, accumulated and selected together, can move:
hair → size → robusticity → musculature → feet → proportions → voice
Then we can eventually feed those parameter ranges into that phenotype compiler idea.
So Track A gave us a useful negative:
Zana ≠ obvious known hypertrichosis/gigantism CNV case.
It did not give us:
Zana proven phenotypically ordinary.
